| Melvyn Acosta-ruiz Sr, MD | |
|
53 Calle Domingo Rubio, Arecibo, PR 00612-4433 | |
| (787) 878-3304 | |
| (787) 878-3304 |
| Full Name | Melvyn Acosta-ruiz Sr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 53 Calle Domingo Rubio, Arecibo, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063476745 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 002512 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melvyn Acosta-ruiz Sr, MD Po Box 1907, Arecibo, PR 00613-1907 Ph: (787) 878-3304 | Melvyn Acosta-ruiz Sr, MD 53 Calle Domingo Rubio, Arecibo, PR 00612-4433 Ph: (787) 878-3304 |
News Archive
Research published in Cell on 29th August by the groups of Filipe Cabreiro from the MRC London Institute of Medical Sciences and Imperial College and Christoph Kaleta from Kiel University in Germany has demonstrated that diet can alter the effectiveness of a type-2 diabetes drug via its action on gut bacteria.
Educational leaders from Boston University School of Medicine believe teaching the subject of unhealthy substance use must be incorporated into internal medicine residency training and can be done within existing teaching venues. The findings, which currently appear on-line in BioMedCentral Medical Education, represent a national model for addressing this issue for internal medicine residents.
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced positive top-line results from a pivotal, non-human primate study of its novel, once-a-day, oral antibiotic Restanza(TM) (cethromycin) against an inhaled lethal dose of tularemia. A 14-day course of Restanza achieved a 100% survival rate at the doses tested. All of the ten animals in the study that received 16 mg/kg once-a-day of Restanza (approximate to a human dose of 300 mg) within 24 hours after exposure to a lethal dose of inhaled tularemia survived while only one of the ten animals that received placebo survived.
Canbiola, Inc. a developer, manufacturer and seller of a variety of Cannabidiol based products such as oils, creams, moisturizers, chews, isolate, gel caps, concentrate and water, announced today the launch and availability of a revolutionary Sustained Acoustic Medicine wellness solution.
› Verified 3 days ago
Francisco Garcia-cortes, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 47 Calle Morell Campos, Arecibo, PR 00612 Phone: 787-878-9300 Fax: 787-879-3372 | |
Juan C Peraza Delgado, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 258 Calle Ventura Gandarilla, Arecibo, PR 00612 Phone: 787-878-4150 | |
Jose R Davila-torres, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 53 Calle Andres Garcia, Instituto Del Cancer Y Enfermedades De La Sangre, Arecibo, PR 00612 Phone: 787-817-4973 Fax: 787-817-4997 | |
Luis Rafael Gonzalez, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 58 Ave Barbosa, 58, Arecibo, PR 00612 Phone: 787-878-1908 Fax: 787-878-0421 | |
Mrs. Sandra E Betancourt, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Urb San Lorenzo Calle Pedro Mora, Suite 1, Arecibo, PR 00612 Phone: 787-817-2512 Fax: 787-816-7364 | |
Dr. Victor Luis Perez-gonzalez, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: Urb Villa Los Santos Calle 16 V 1, Arecibo, PR 00612 Phone: 787-879-1585 |